Innova Captab's Q2 FY 2025-26 Quarterly Results

Result Summary

• Innova Captab Ltd reported a 8.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 20.0%.
• Its expenses for the quarter were up by 10.2% QoQ and 26.2% YoY.
• The net profit decreased 4.4% QoQ and decreased 15.2% YoY.
• The earnings per share (EPS) of Innova Captab Ltd stood at 5.18 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Innova Captab Ltd is a company whose primary business activities involve the manufacturing and distribution of pharmaceuticals. The company operates within the healthcare sector, focusing on the development of generic and specialty pharmaceutical products. As of the latest available data, there have been no specific recent major developments publicly recorded. The company is known for its commitment to delivering high-quality healthcare products, although further detailed information about its product portfolio or recent strategic initiatives is not available within the provided data.

Revenue

For the quarter ending Q2FY26, Innova Captab Ltd reported a total income of ₹384.57 crores. This represents an 8.0% increase compared to the previous quarter (Q1FY26), where the total income was ₹356.02 crores. Year-over-year, the total income saw a substantial increase of 20.0% from ₹320.42 crores in Q2FY25. These figures indicate a robust growth in revenue on both a quarterly and annual basis, highlighting a positive trend in the company's ability to generate income.

Profitability

The company's profitability, as measured by its Profit Before Tax (PBT), was ₹39.24 crores in Q2FY26. This reflects a decrease of 8.1% from the preceding quarter (Q1FY26), where the PBT was ₹42.68 crores. Compared to the same quarter in the previous year (Q2FY25), there was a notable decline of 16.2%, with the PBT having been ₹46.81 crores. Profit After Tax (PAT) for Q2FY26 was ₹29.67 crores, down by 4.4% from ₹31.02 crores in Q1FY26, and down by 15.2% from ₹35.00 crores in Q2FY25. The Earnings Per Share (EPS) also reflected these trends, decreasing by 4.4% QoQ and 15.4% YoY, standing at ₹5.18 in Q2FY26.

Operating Metrics

For the quarter ending Q2FY26, total expenses amounted to ₹345.34 crores, marking a 10.2% rise from the previous quarter's expenses of ₹313.34 crores, and a 26.2% increase from ₹273.61 crores in Q2FY25. These figures suggest that the company's operational costs have increased significantly over both the quarterly and annual periods. The taxation for Q2FY26 was ₹9.56 crores, representing an 18.0% decrease from Q1FY26, where the tax was ₹11.66 crores, and a 19.0% decrease from ₹11.80 crores in Q2FY25. This reduction in tax expense aligns with the decline in profitability metrics. The data provided does not include enough information to calculate other financial ratios like P/E ratio, debt-to-equity ratio, or current ratio. The trends in the data reflect changes in both revenue and expenses, impacting the overall financial performance.